Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment
- 1 July 2004
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 28 (4) , 709-713
- https://doi.org/10.1016/j.pnpbp.2004.05.008
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controlsNeuroscience Letters, 2003
- Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophreniaMolecular Psychiatry, 2003
- NEUROTROPHINS AND SYNAPTIC PLASTICITYAnnual Review of Neuroscience, 1999
- Transport of brain-derived neurotrophic factor across the blood–brain barrierNeuropharmacology, 1998
- Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampusNature, 1996
- Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassayBrain Research, 1996
- Neurotrophins and Neuronal PlasticityScience, 1995
- Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitaryEndocrinology, 1995
- Molecular Psychiatry Adaptations of Receptor-Coupled Signal Transduction Pathways Underlying Stress- and Drug-Induced Neural PlasticityJournal of Nervous & Mental Disease, 1994
- The APUD concept and hormone productionClinics in Endocrinology and Metabolism, 1980